| |
 |
|
Class Information
Number: 546/142
Name: Organic compounds -- part of the class 532-570 series > Organic compounds (class 532, subclass 1) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., oxygen, sulfur, selenium, or tellurium) or nitrogen as the only ring hetero atoms (class 540, subclass 1) > Hetero ring is six-membered consisting of one nitrogen and five carbons > Polycyclo ring system having the six-membered hetero ring as one of the cyclos > Bicyclo ring system having the six-membered hetero ring as one of the cyclos > Isoquinolines (including hydrogenated) > Chalcogen attached directly to the six-membered hetero ring by nonionic bonding > Plural chalcogens attached directly to the six-membered hetero ring by nonionic bonding
Description: Compounds wherein at least two chalcogens (i.e., oxygen, sulfur, selenium, or tellurium) are attached directly to the six-membered hetero ring of the isoquinoline ring system by nonionic bonding.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7615565 |
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines |
Nov. 10, 2009 |
| 7345062 |
Substituted acylhydroxamic acids and method of reducing TNF.alpha.levels |
Mar. 18, 2008 |
| 7205315 |
Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases |
Apr. 17, 2007 |
| 7173057 |
Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus |
Feb. 6, 2007 |
| 7153963 |
Phenylalanine derivatives |
Dec. 26, 2006 |
| RE39265 |
Heteroarylpiperidines, and their use as antipsychotics and analgetics |
Sep. 5, 2006 |
| 7030201 |
Bottom antireflective coatings |
Apr. 18, 2006 |
| 6906063 |
Platelet ADP receptor inhibitors |
Jun. 14, 2005 |
| 6870055 |
Isoquinolinone potassium channels inhibitors |
Mar. 22, 2005 |
| 6818774 |
Isoquinoline derivatives |
Nov. 16, 2004 |
| 6720427 |
Thiazole derivatives |
Apr. 13, 2004 |
| 6716853 |
Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase |
Apr. 6, 2004 |
| 6699899 |
Substituted acylhydroxamic acids and method of reducing TNF.alpha. levels |
Mar. 2, 2004 |
| 6656910 |
Serine protease inhibitors |
Dec. 2, 2003 |
| 6656911 |
Serine protease inhibitors |
Dec. 2, 2003 |
| 6602867 |
Triazole compounds with dopamine-D3-receptor affinity |
Aug. 5, 2003 |
| 6602864 |
Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds |
Aug. 5, 2003 |
| 6586447 |
3,3-disubstituted-oxindole derivatives useful as anticancer agents |
Jul. 1, 2003 |
| 6479436 |
Hetaroyl cyclohexanedione derivatives with herbicidal effect |
Nov. 12, 2002 |
| 6472405 |
Glycoprotein IIB/IIIA antagonists |
Oct. 29, 2002 |
| 6452009 |
4-unsubstituted dihydroisoquinolinone derivatives and combinatorial libraries thereof |
Sep. 17, 2002 |
| 6417178 |
Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits |
Jul. 9, 2002 |
| 6403607 |
Sulfonamide derivatives and drugs containing the same as the active ingredient |
Jun. 11, 2002 |
| RE37729 |
4-Heteroaryl-1-piperidinealkylamines and derivatives thereof and their therapeutic utility |
Jun. 4, 2002 |
| 6362193 |
Cycloalkenyl substituted compounds |
Mar. 26, 2002 |
| RE37478 |
1-(arylthioalkyl, arylaminoalkyl, or arylmethylenealkyl)-4-(heteroaryl)piperazines and related compounds useful as antipsychotics and analgesics |
Dec. 18, 2001 |
| 6281227 |
Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
Aug. 28, 2001 |
| 6262068 |
Lactam derivatives as antiarrhythmic agents |
Jul. 17, 2001 |
| 6255479 |
Process for the preparation of .alpha.-oxolactams |
Jul. 3, 2001 |
| 6214857 |
Substituted alkanohydroxamic acids and method of reducing TNF.alpha. levels |
Apr. 10, 2001 |
| RE37029 |
N-[(3-heteroaryl-1-pyrrolidinyl)-alkyl]phthalimides and related compounds and their therapeutic utility |
Jan. 23, 2001 |
| 6174901 |
Substituted pyridine and pyridazine compounds and methods of use |
Jan. 16, 2001 |
| 6168776 |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
Jan. 2, 2001 |
| 6166219 |
Benzimidazole derivatives |
Dec. 26, 2000 |
| 6140339 |
Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof |
Oct. 31, 2000 |
| 6040442 |
Process for preparing 1,2,5-thiadiazole containing ethers |
Mar. 21, 2000 |
| 6020343 |
(Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
Feb. 1, 2000 |
| 6015820 |
4-Aryl-thio-pyridin-2(1H)-ones, medicines containing them and their uses in the treatment of illnesses linked to HIV |
Jan. 18, 2000 |
| 5977367 |
N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands |
Nov. 2, 1999 |
| 5925637 |
Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |
Jul. 20, 1999 |
| 5866579 |
Imidazole and imidazoline derivatives and uses thereof |
Feb. 2, 1999 |
| 5861380 |
Serine protease inhibitors-keto and di-keto containing ring systems |
Jan. 19, 1999 |
| 5837703 |
Amino-alcohol substituted cyclic compounds |
Nov. 17, 1998 |
| 5776963 |
3-(heteroaryl)-1-[(2,3-dihydro-1h-isoindol-2-yl)alkyl]pyrrolidines and 3-(heteroaryl)-1-[(2,3-dihydro-1h-indol-1-yl)alkyl]pyrrolidines and related compounds and their therapeutic untility |
Jul. 7, 1998 |
| 5767141 |
Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
Jun. 16, 1998 |
| 5741798 |
2-benzyl-4-sulfonyl-4H-isoquinolin-1,3-diones and their use as antiinflammatory agents |
Apr. 21, 1998 |
| 5739134 |
N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2h-benzopyran, dihydrobenzodioxin, benzodioxole, dihydrobenzodioxepin, or tetrahydrobenzoxepin)carboxamide derivatives |
Apr. 14, 1998 |
| 5728712 |
3,4-disubstituted-phenylsulphonamides and their therapeutic use |
Mar. 17, 1998 |
| 5728715 |
Dihydropyridazinones, pyridazinones and related compounds as fungicides |
Mar. 17, 1998 |
| 5728844 |
Immunotherapeutic agents |
Mar. 17, 1998 |
|
|
|